Short-term prediction of secondary progression in a sliding window: A test of a predicting algorithm in a validation

B Skoog1, J Link2, H Tedeholm1

  • 1University of Gothenburg, the Sahlgrenska Academy, Institute of Neuroscience and Physiology, Section of Clinical Neuroscience and Rehabilitation, Sweden.

Abstract

Insights

The Multiple Sclerosis Prediction Score (MSPS) accurately predicts secondary progression risk in relapsing-remitting multiple sclerosis patients. Calibration enhances its generalizability across different cohorts.

Area of Science:

  • Neurology
  • Clinical Epidemiology

Background:

  • The Multiple Sclerosis Prediction Score (MSPS) is a tool to estimate individual risk of secondary progression (SP) in relapsing-remitting multiple sclerosis (MS).
  • Accurate prediction of SP is crucial for managing MS progression and treatment strategies.

Purpose of the Study:

  • To internally verify the MSPS algorithm using the Gothenburg Incidence Cohort (GIC).
  • To externally validate the MSPS algorithm in the independent Uppsala MS cohort (UMS).

Main Methods:

  • Patients with relapsing-remitting MS were followed for up to 25 years from their second relapse.
  • A goodness-of-fit test and diagnostic plots were used to compare predicted versus observed transitions to SP.
  • The MSPS algorithm was calibrated using multiplicative factors specific to each cohort.

Main Results:

  • The median time to SP was 11.5 years in the GIC and 15 years in the UMS.
  • Calibrated MSPS showed a good fit between expected and observed outcomes in the UMS (chi-square p=0.61).
  • Calibration factors were 0.829 for GIC and 0.599 for UMS.

Conclusions:

  • The MSPS demonstrates clinically relevant generalizability to new multiple sclerosis cohorts.
  • Calibration of the MSPS to the specific SP incidence of a cohort is essential for its reliable application.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
473
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
143
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
175
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
293